Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Megan A. Files"'
Autor:
Megan A. Files, Kubra F. Naqvi, Tais B. Saito, Tara M. Clover, Jai S. Rudra, Janice J. Endsley
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-14 (2022)
Abstract Heterologous vaccine regimens could extend waning protection in the global population immunized with Mycobacterium bovis Bacille Calmette-Guerin (BCG). We demonstrate that pulmonary delivery of peptide nanofibers (PNFs) bearing an Ag85B CD4+
Externí odkaz:
https://doaj.org/article/74cb267c345f461e8f9ffd236df85864
Autor:
Megan A. Files, Clairissa A. Hansen, Vanessa C. Herrera, Craig Schindewolf, Alan D. T. Barrett, David W. C. Beasley, Nigel Bourne, Gregg N. Milligan
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-10 (2022)
Abstract Oropouche virus (OROV) is an arthropod-borne orthobunyavirus found in South America and causes Oropouche fever, a febrile infection similar to dengue. It is the second most prevalent arthropod-borne viral disease in South America after dengu
Externí odkaz:
https://doaj.org/article/1fc87419843048a4a1637e617990b314
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Development of novel immunization approaches to combat a growing list of emerging and ancient infectious agents is a global health priority. Intensive efforts over the last several decades have identified alternative approaches to improve upon tradit
Externí odkaz:
https://doaj.org/article/2391c80efb884d2597ee572461a7469b
Publikováno v:
Acta biomaterialia
Currently approved replication-competent and inactivated vaccines are limited by excessive reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently immunogenic without co-administering exogenous adjuvants. Self-assembl
Autor:
Zain P. Clapacs, Paresh C. Shrimali, Giriraj Lokhande, Akhilesh K. Gaharwar, Megan A. Files, Darren D. Kim, Conor L. O'Neill, Jai S. Rudra
Publikováno v:
Biomacromolecules. 23(3)
Alginate hydrogels are widely used for tissue engineering and regenerative medicine due to their excellent biocompatibility. A facile and commonly used strategy to crosslink alginate is the addition of Ca2+ that leads to hydrogelation. However, extra
Autor:
Megan A, Files, Kubra F, Naqvi, Tais B, Saito, Tara M, Clover, Jai S, Rudra, Janice J, Endsley
Publikováno v:
NPJ vaccines. 7(1)
Heterologous vaccine regimens could extend waning protection in the global population immunized with Mycobacterium bovis Bacille Calmette-Guerin (BCG). We demonstrate that pulmonary delivery of peptide nanofibers (PNFs) bearing an Ag85B CD4
Autor:
Megan A, Files, Clairissa A, Hansen, Vanessa C, Herrera, Craig, Schindewolf, Alan D T, Barrett, David W C, Beasley, Nigel, Bourne, Gregg N, Milligan
Publikováno v:
NPJ vaccines. 7(1)
Oropouche virus (OROV) is an arthropod-borne orthobunyavirus found in South America and causes Oropouche fever, a febrile infection similar to dengue. It is the second most prevalent arthropod-borne viral disease in South America after dengue. Over 5
Autor:
Jimin Xu, Jia Zhou, Jeffrey D. Cirillo, Mark A. Endsley, Janice J. Endsley, Xiu Zhen Fan, Megan A. Files
Publikováno v:
Tuberculosis (Edinburgh, Scotland)
The human immunodeficiency virus (HIV) pandemic is driving the re-emergence of tuberculosis (TB) as a global health threat, both by increasing the susceptibility of HIV-infected people to infection with Mycobacterium tuberculosis (Mtb), and increasin
Publikováno v:
The Journal of Immunology. 204:166.1-166.1
Human immunodeficiency virus (HIV) is the world’s sixth leading cause of death. Antiretroviral therapy (ART) is the current standard of treatment, but issues of accessibility and compliance pose additional hurdles. In 2018, there were 37.9 million
Publikováno v:
The Journal of Immunology. 202:139.2-139.2
Tuberculosis (TB) infection caused by Mycobacterium tuberculosis (Mtb) is a serious threat to global health with 10 million new infections each year and 1–2 million deaths. The only licensed vaccine approved for human use, Mycobacterium bovis Bacil